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ABSTRACT
Mitochondrial dysfunction is a contributing factor to the advancement of various diseases
including obesity, diabetes, and cardiovascular disease. Impairment in mitochondria brings about
a diminished mitochondrial number and oxidative capacity. Leucine is known to stimulate
muscle protein synthesis through transcription and translation of nuclear DNA leading to
increases in mitochondrial biogenesis and fatty acid oxidation. However, the effects of leucine
on anabolic factors of the mitochondrial genome, during catabolic conditions are not known.

<bold> PURPOSE </bold> : To determine if leucine supplementation alters the negative
effects of a high fat (60%) diet (HFD) on the mitochondrial genome by measuring the gene
expression of mitochondrial protein synthesis markers TFAM, mtIF2, and TUFM, and
mitochondrial biogenesis regulatory factors PGC-1α and COX-IV. <bold> METHODS

</bold : Male, Sprague-Dawley rats (n = 30 / dietary treatment) were fed either a control diet
(C), control + leucine (CL), high-fat (HF), or high-fat + leucine (HFL) for 42 days. At the
conclusion of 42 days, the soleus was extracted and used for analysis. Quantitative PCR was
conducted to determine gene expression for PGC-1α, TFAM, mtIF2, TUFM, and COX-IV.

<bold> RESULTS </bold>:: mtIF2 gene expression increased 4-fold (p < 0.05) and TFAM
gene expression increased 5-fold, with a control diet supplemented with leucine, respectively.
mtIF2 gene expression increased 4-fold (p < 0.05) in response to a HFD compared to normal
chow. However, TUFM gene expression declined (p < 0.05) in response to a HFD with or
without leucine. <bold> CONCLUSION</bold>:: Leucine supplementation did not stimulate
an increase in TFAM, mtIF2, and TUFM when exposed to a HFD, but does however stimulate
an increase of mitochondrial protein synthesis markers in normal conditions. Indicating enhanced
mitochondrial protein synthesis with leucine supplementation, at least under normal conditions.
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CHAPTER 1
INTRODUCTION
Obesity, the most common disorder in the United States and developing countries, is
largely due to excess food intake and a lack of physical exercise (9). Major risk factors and
comorbidities are associated with obesity including, diabetes, cardiovascular disease,
musculoskeletal disorders, and carcinogenesis. With this increase in complications resulting from
becoming obese, the individuals affected by this disease are experiencing a loss in high quality
and productive life years. These illness states are regularly associated with an abnormal
metabolism along with, lessened glucose uptake, modified protein turnover, and dysregulated
lipid metabolism (21).
Increasing evidence suggests mitochondrial dysfunction to be a causative factor in many
metabolic diseases including, obesity, diabetes, and cardiovascular disease (26, 35, 49, 52).
These disruptions are often triggered by an increase flux of fatty acids (FAs), concomitant with
the inability to switch carbohydrate fuel supplies, resulting from a high-fat diet (HFD). However,
the underlying mechanisms of metabolic adaptation in response to HFD are only beginning to be
unraveled, and the cause-and-effect relationship between HFD and mitochondrial dysfunction
remain unclear.
Mitochondria play a key role in whole body metabolic homeostasis by regulating several
metabolic processes including, oxidative phosphorylation (OXPHOS), FA β-oxidation, reactive
oxygen species (ROS), amino acid metabolism, and calcium homeostasis (37). Thus a change in
metabolism, regarded as “mitochondrial dysfunction” has not been an uncommon result seen in
the skeletal muscle of obese rodents (7, 53, 67) and humans (34, 62). One of the primary means
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of increasing skeletal muscle oxidative capacity is through mitochondrial biogenesis (11).
Mitochondrial biogenesis is the main process by which an increase in mitochondrial content and
improvement of the functional capabilities of pre-existing mitochondria can be made (55).
Interventions aimed to enhance mitochondrial biogenesis, and thereby mitochondrial
functions have been reported to modulate insulin signaling and metabolic defects (59). Many
strategies for preventing obesity have concentrated on dietary and lifestyle changes, for example,
caloric restriction and becoming more active. These studies have revealed that despite the fact
that weight loss can be achieved by modified dietary approaches, dieters find it difficult to
maintain their weight loss over a certain time period (33). A growing body of data has
demonstrated a unique signaling role of the branched-chain amino acid (BCAA), leucine, on
improving lipid and glucose metabolism (68). In these cells, leucine increased muscle protein
synthesis via activation of the mammalian target of rapamycin signaling pathway (mTOR) (13),
stimulated mitochondrial biogenesis (13), as well as fatty acid oxidation (45).
Further data suggests that leucine stimulates SIRT-1, an activator of PGC-1α, which is
associated with the initiation of mitochondrial biogenesis and fat oxidation in skeletal muscle
cells (17). PGC-1α activates mitochondrial biogenesis and increases OXPHOS gene expression
(21) by increasing the transcription, translation, and activation of transcription factors necessary
for mitochondrial biogenesis. Among them, transcription factor of activated mitochondria
(TFAM) is one of the regulatory factors needed for proper transcription of mitochondrial DNA
(mtDNA) (49). In a 2007 study by Turner et al. (69), mitochondrial biogenesis and FA oxidative
capacity was shown to be enhanced in skeletal muscle of mice on a HFD.
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However, mitochondria are equipped with their own protein synthesis machinery,
encompassing 13 protein-encoding genes that are all essential in the function of the electron
transport system, and paramount to metabolic health. Two nuclear-encoded proteins,
mitochondrial translation initiation factor 2 (mtIF2) and mitochondrial translation elongation
factor-Tu (TUFM) have been identified as essential components of the mitochondrial translation
process. mtIF2 and TUFM are translated in the cytosol by the canonical translation machinery,
and imported to the mitochondria where they are primarily responsible for the translation
initiation and elongation processes (47).
Leucine supplementation has been well documented in stimulating certain protein
synthesis related anabolic processes. However, the effect of leucine supplementation on the
mitochondrion transcriptional and translational machinery in a catabolic situation, caused by
HFD has yet to be established. The present study evaluates the impact of a HFD on markers of
mitochondrial protein synthesis and mitochondrial biogenesis in rat soleus muscle. We further
determined the effect of leucine supplementation on the anabolic factors involved in
mitochondrial protein synthesis and mitochondrial biogenesis in the soleus muscle of rats
submitted to a HFD.
CHAPTER 2
REVIEW OF LIERATURE
This literature review is divided by topic into 5 main sections: 1) Obesity and the adverse
effects on health status, 2) skeletal muscle and the functional changes in response to high-fat
feeding, 3) mitochondrial regulation and its role in energy metabolism, 4) mitochondrial
biogenesis as it relates to the regeneration of damaged mitochondria, and 5) the anabolic role of
leucine in muscle protein synthesis and mitochondrial regulation. This review will include
3

	
  

general knowledge on high-fat feeding and how it has been shown to effect muscle protein
synthesis in previous research, as well as how the mitochondrial dysfunction occurs in muscle
under catabolic conditions. The two components of mitochondrial processes that will be
examined in this study include protein synthesis and mitochondrial biogenesis. Previous
literature on markers of mitochondrial biogenesis and oxidative capacity, (PGC-1α and COX-IV)
and the role these play in mitochondrial biogenesis within skeletal muscle will be reviewed.
Markers of mitochondrial protein synthesis including TFAM, mtIF2, and TUFM, will be
reviewed in their role in the transcriptional and translational processes.
I.

Obesity
The rising epidemic of obesity is a leading health concern over the globe. The World

Health Organization (WHO) characterizes obesity as a state of unusual fat mass gathered in
adipose tissue, which may cause extreme health consequences (9). Obesity is the most frequently
encountered metabolic disease across the world (9). In the United States, obesity is currently
prevalent in more than two-thirds of the adult population, with rates anticipated to expand later
on without mediation (54). Research has also shown that a key predictor of high blood pressure,
type 2 diabetes, cardiovascular disease, and premature death are associated with obesity (29).
Body mass index (BMI) is an indirect measure of obesity with a correlation to body fat
mass in children, and adults (51). A BMI value greater than or equal to 30 kg/m2 is inferred to as
being obese (75). Among adults, a greater proportion of men (41.2%) are overweight contrasted
with women (28.4%), and women are more probable than men to be obese (75). The changes
that have been brought by industrialization have negative impacts on both diet and physical
activity levels which illustrates a piece of the expanding patterns in obesity over the previous
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decade. Despite the poor health outcomes that arise due to excessive intake of energy-dense
foods, the trend for obesity shows no sign of plateauing. Therefore, it is imperative to understand
the physiological changes associated with the onset of obesity and determine an intervention that
will prevent or attenuate impaired metabolic function.
Complications and Comorbidities Associated with Obesity
Complications of obesity in adults include dyslipidemia, type 2 diabetes, coronary illness,
hypertension, disease, and premature death (74). Alongside the expansion in rate of obesity in
adults, is complication of obesity infrequently seen in pediatric populace, for example: type 2
diabetes, hypertension, cardiovascular ailment, and metabolic syndrome is getting more
pervasive. Due to the expansion in complexities associated with obesity, those who are
influenced by this ailment experience a decline in a high quality life when exposed to this
sickness in early phases of life (69). It has likewise been recognized that when people are
corpulent in their young lives, they encounter more trouble in losing this weight, so the
overweight child usually turns into an overweight or obese adult.
Obesity has also been shown to prompt insulin and leptin resistance, which brings about
dysfunctional adipose and skeletal tissue (73). At the point when this happens, metabolic
dysregulation occurs with hoisted levels of circulating free fatty acids (FFAs), and increased
generation and discharge of pro-inflammatory adipokines. If left untreated, can prompt
conditions such as liptoxicity, chronic inflammation, hypertension, atherosclerosis, and
cardiovascular disease (68). As BMI increases, systolic and diastolic blood pressure additionally
expand (63). An obese individual normally shows a debilitated lipid profile, where triglycerides
are raised, HDL-cholesterol concentration is lessened, and low-density lipoprotein levels are
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raised (63). It is likewise vital to note that visceral fat amassing is more risky for the
advancement of cardiovascular ailment than fat on the extremities. Additionally, there is a link
between obesity and advancement of type 2 diabetes with an increased risk of developing prediabetic conditions as an aftereffect of impeded glucose tolerance, and insulin resistance in the
tissues (69).
The huge number of complications and comorbidities connected with obesity not only
cause human suffering and diminished personal satisfaction in a few cases, but this also decides
the surprising expenses connected with obesity. The assessed expenses of obesity extend from
6% to 16% of aggregate medicinal services in the United States (54). This expense is likely
going to climb with ease of access to unhealthy sustenance’s (54) and the decline of physical
activity around occupants of the United States, as well as in developing nations. Due to the rising
obesity epidemic and its connected comorbidities, it is critical to expand research addressing the
issue.
Etiology of Obesity
There are many genes that are connected with energy metabolism, and there is now
interest toward variables that have been illustrated to partake in the commitment of an
individual’s vulnerability to put on weight and create comorbidities connected with obesity. The
recent investigated supporters to the surge in obesity include diseases, lack of sleep, and a
diminishment in an assortment of surrounding temperatures, mitochondrial dysfunction, aging,
and assortative mating alongside epigenetics (16). This research focus has recently come of
interest because of the now known effect of different supplements, and environmental
compounds on the mitochondrial genome, which can prompt more serious disease processes.
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II.

Skeletal Muscle

Structure and Function
Skeletal muscle is a standout amongst the most specialized structures in the whole body
framework. There are in excess of 400 skeletal muscles, which constitute 40 percent to half of
the total body mass, therefore making it the largest organ in the human body (73). Skeletal
muscle cells (myofibers) are the fundamental unit of a singular skeletal muscle, and are
comprised of many nuclei. Encompassing an individual nucleus is a district of cytoplasm known
as the myonuclear domain (79). The nucleus assumes a critical part in the gene expression for its
encompassing myonuclear area.
Muscle fibers can adjust to quick or moderate twitch activity. This variation starts from a
functional demand of the myofibers, and is fortified by incitement of fiber type-specific
contractions (79). There are two principle contractile fiber types: glycolytic (type I) and
oxidative (type II) fibers. Glycolytic muscles, for example, the gastrocnemius, are basically made
out of fast twitch fibers and produce energy by means of anaerobic metabolic techniques.
Oxidative muscles, such as soleus, are slower to contract yet oppose fatigue at a slower pace by
means of oxidative metabolic methods (10).
The peripheral region of the central nervous system (CNS) controls the skeletal muscles.
In this manner, skeletal muscle is under cognizant or voluntary control. Voluntary movement is
critical to the survival of humans, and is contributed to an endless show of proteins found in the
mature skeletal muscle myofiber (79). Skeletal muscle is critical for exercises of day-by-day
living, and obliges the facilitated regulation of inflammation, protein synthesis, and protein
degradation for ideal muscle development (73). The three primary functions of the skeletal
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muscle are force production of body movement and respiration, posture support, and body heat
processing (73).
Adenosine triphosphate (ATP) is a molecule that stores energy inferred from
nourishments, and exchanges the energy to cells for biochemical processes (5). All muscles
require ATP to produce contractions and movement. The capacity of the skeletal muscle cell is
energized by glucose and lipid oxidation. Under ordinary augmenting conditions, glycolytic
muscles use glucose, while oxidative muscles depend all the more on lipids (64). During physical
activity, muscle cells are enacted and enhance their contractile performance. Conversely,
muscles that do not undergo regular activity consider the opposing effect.
Protein Synthesis
Protein is an essential macromolecule, which helps make the structural component of
cells, and is used within many biologic reactions (2). Proteins are composed of a vast array of
smaller units called amino acids, connected in long chains. Twenty diverse amino acids are
required in a particular order to characterize every protein’s shape and function. There are a
multitude of specialized proteins that are involved in cellular activity including, insulin and
muscle cell filaments. All things considered, proteins assume an essential part in the shaping of
muscle tissue, and help support a healthy, and dynamic body.
Protein synthesis is an event that occurs in all the cells of the body via transcription and
translation processes. Messenger ribonucleic acid (mRNA) is synthesized in the nucleus where it
receives the instructions from DNA (transcription) and transfers the code into the cytoplasm
where protein synthesis occurs. Ribosomal RNA (rRNA) specializes in the manufacture of
ribosomes, the organelle that mRNA binds to in order to transfer the genetic code. Transfer RNA
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(tRNA) resides in the cell cytoplasm, and is responsible for supplying the ribosomes with amino
acids for protein synthesis (translation). After completion, the protein is removed from the
ribosome and used as a structural component of a cell, or released to perform its proper function.
A decline in skeletal muscle protein synthesis may have a negative impact on biological
processes, and thus affect optimal health.
III.

Mitochondrial Regulation

Mitochondrial Dysfunction in Health and Disease
Within each cell are tiny sub-cellular organelles known as, mitochondria, that extract
substantial amounts of energy from consumed nutrients, in order to fuel each individual cell and
ultimately the whole human body (5). Mitochondria assume a crucial role in cellular metabolism,
energy homeostasis, cell signaling, and apoptosis (25). Without mitochondria, the production of
energy and all cellular functions would be compromised. Hence, maintaining abundant,
functional mitochondria is essential to sustain life.
An expansion of literature distinguishes mitochondrial dysfunction as a contributing factor to
various pathophysiologies (25, 78). Given its significant role in the cell, it comes as no surprise
that harm to mitochondria ultimately prompts disease (15). Case in point, mitochondrial
dysfunction is perceived as a causative element in a wide assortment of disease states, which
include obesity, diabetes, cardiovascular disease, cancer, and dementia (15, 78). The
commonality amongst these disease pathophysiologies comes from the generation of ROS that
bring about the accumulation of damage to mitochondrial DNA (mtDNA) (25). This eventually
prompts mitochondrial dysfunction, resulting in more ROS; accordingly sustaining an endless
loop (25). This mixture of oxidative stress and mitochondrial dysfunction is common to various
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conditions; thus, the identification of factors that can attenuate oxidative stress and mitochondrial
function is significant (22).
Mitochondrial Structure and Function
Mitochondria have a double membrane, bringing about different compartments inside the
organelle. The semi-porous external mitochondrial membrane encases the organelle,
differentiating it from the cytosol (27). The intermembrane space is located between the outer
and inner membrane, and serves as an area for protein transport. Imbedded in the mitochondrial
inner membrane are the enzymes responsible for extracting energy from food via ATP synthases
and oxidative phosphorylation (OXPHOS) (32). The inner membrane is further
compartmentalized to structure cristae, which builds the surface region in this way expanding the
organelles capacity to synthesize ATP (32). Lastly, the mitochondrial matrix is the space within
the mitochondrial membrane, and is the site of the citric acid cycle (also known as Krebs cycle)
and also unsaturated fat oxidation (32).
Fuel substrates such as, glucose, lipids, and fatty acids combine with oxygen to produce
energy via OXPHOS and electron transport system (ETC), which is used to synthesize ATP. The
ATP then spreads through the cell, and the required energy stored within the phosphate bonds of
ATP is released to support cellular functions (15). The mitochondrial ETC consists of a series of
redox reactions, where the substrates NADH and FADH2 donate electrons to a terminal election
acceptor, oxygen. The outcome of electron transport is to build up a proton gradient outside the
inner mitochondrial membrane. The resulting proton gradient navigates the inner mitochondrial
membrane back to the matrix, thus activating the membrane ATP synthase and producing 80%
of the cellular ATP.
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OXPHOS involves an electrochemical gradient, whereby high-energy electrons of
NADH are converted into ATP’s high-energy bonds. OXPHOS pathways do not require oxygen
to produce ATP. The OXPHOS system consists of 5 multi-protein enzyme complexes (I-V) that
all contribute in transporting electrons and proteins. The three protein pumps include complexes
one, three, and four (42). Cytochrome c oxidase or complex IV (COX-IV) is an enzyme that
catalyzes the final step in the electron transfer, and is considered a major regulation site for
OXPHOS (42).
While the primary responsibility of mitochondria is to produce ATP, this organelle is
vital for various cell processes including cellular energy metabolism, cell signaling and apoptosis
(25). As the primary site of citric acid cycle, lipolysis, and OXPHOS, mitochondria contain
enzymes vital for the synthesis of lipids, cholesterol, heme, and assume a basic part in amino
acid metabolism (25). Also, ROS are a product of mitochondria during OXPHOS. This
controlled era of ROS by the mitochondria is vital for both cell signaling and apoptosis (25).
Mitochondrial Protein Synthesis
Each mitochondrion in a cell comprises its own genome (mtDNA), which is entirely
separate from the DNA found in the nucleus (nuclear DNA). The mtDNA plays a key role in the
expression of the respiratory chain. The components that make up the mitochondrial genome
include, a large rRNA, small rRNA, proteins, and 22 tRNAs that are necessary for the translation
of the RNA made by the mitochondria (32). Muscle mitochondrial content is a key factor of
aerobic exercise capacity in healthy subjects.
The mitochondrial genome codes for a very limited number of proteins, and rely on the
nuclear DNA to provide the structural and enzymatic machinery required for protein synthesis.
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There are more than 95% of proteins encoded in the nuclear DNA, synthesized in the cytoplasm,
and transported to the mitochondria (21). Despite the limited amount of protein in the mtDNA,
each protein is paramount in the expression of the respiratory chain, and thus mitochondrial
health. The mitochondrial genome undergoes the same transcription and translation processes as
nuclear DNA, but consists of different control proteins that are significant in the proper function
of protein synthesis. Enzyme and transcription factors encoded in the nucleus direct the
transcription of mtDNA. Transcription factors are regulatory proteins responsible for the
expression of nuclear genes encoding respiratory chain proteins (21).
The initiation of transcription begins at the heavy (PH) and light (PL) strand promoter sites
of the DNA strand. The PH strand is responsible for coding most of the 13 genes that are encoded
by the mtDNA, as well as, tRNA’s that are needed for proper translation into proteins (73).
Transcription factors such as, mitochondrial transcription factor A (TFAM) are needed to ensure
proper transcription of mtDNA, and of genes involved in the respiratory complexes (73). Both,
PH and PL promoter sites, share an upstream enhancer that denotes the recognition site for
TFAM. Transcription is then stimulated through specific binding to these recognition sites.
TFAM also plays a role in stabilizing and maintaining the mitochondrial genome through
nonspecific binding to random sites on mtDNA at a high affinity. Previous findings on TFAM
knockout mouse concluded that, without TFAM embryonic cells were destructible, and there was
a depletion of mtDNA content (71). Thereafter, it was suggested that TFAM levels correlate with
increased levels of mtDNA in ragged-red muscle fibers (72). Ragged-red muscle fibers are
associated with clumps of “diseased” mitochondria. Another study established a correlation
between lower TFAM expression levels with decreased mtDNA levels in cells that contained
depleted mtDNA (65).
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The mitochondrial translation machinery relies on the nuclear genome that encodes
protein necessary for proper translation. The protein components necessary for translation
include, tRNA synthetases, mitochondrial ribosomal proteins, and initiation, elongation, and
termination translation factors (2). The first qualification that must be met in order for translation
to take place is, the mtDNA must be present, maintained, and transcribed (2). Secondly, proteins
encoded in the nuclear genome that are responsible for proper mitochondria function have to be
imported from the cell cytoplasm (2).
Translation Factors
A late report by Mercader et al. (47) implicates two key proteins for the mitochondrial
translation process as novel applicant genes in human type 2 diabetes. These proteins are known
as, mitochondrial translation initiation factor 2 (mtIF2) and mitochondrial translation elongation
factor-Tu (TUFM). mtIF2 and TUFM display essential obligation regarding the translation
initation and elongation processes (21). mtIF2 and TUFM are exceedingly monitored nuclearencoded proteins interpreted inside the cytosol by the standard translation machinery and
imported to the mitochondria (21). There, they are fundamental components of the mitochondrial
translation process inside the mitochondrial matrix (21). Right now, it is accepted that the start of
interpretation happens upon mtIF2 binding to the mitoribosomal small subunit (SSU) which
transports fMET-tRNA to the SSU at the aminoacyl acceptor site for interpretation (translation)
of the mRNA, taking after edit TUFM is then comparably discharged from the unit through GTP
hydrolysis permitting an alternate tRNA-TUFM to come in (21). This methodology proceeds to
the end of the mRNA by means of a comparable stop codon mechanism to nuclear translation.
Smits et al. (66) have beforehand distributed a more detailed audit of this procedure. The exact
regulation of each one stage and protein included is still undetermined. In any case, it creates the
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impression that various translation variables display potential binding sites to the mtIF2 and
TUFM promoters, moreover Hornbeck et al. (28) noted 27 anticipated binding sites for
posttranslational modification of TUFM. It thusly makes sense that complete mitochondrial
biogenesis requires the upregulation of the mitochondrial translation machinery so as to include
these key components.
IV.

Mitochondrial Biogenesis

Mitochondrial functions are controlled, to a limited extent, by progressions in mitochondrial
mass, such that diminished mitochondrial number contributes to a loss of function (68). Strict
control over mitochondrial progress also allows this organelle to have changing reactions based
upon adjustments in the environment such as, physical activity, availability of nutrients, and low
temperature (68). This control is accomplished through mitochondrial biogenesis, which is a
fundamental living methodology needed for development and advancement, in addition to meet
the variable energy necessities of the cell (25). The synthesis, import, and integration of
macromolecules to the mitochondrial reticulum is required in order for mitochondrial biogenesis
to occur. Mitochondrial biogenesis is further convoluted by the presence of double genomes, and
the fundamental replication of the mitochondrial genome (25).
Mitochondria are produced from the transcription and translation of encoded genes in
both the nuclear genome and mitochondrial genome. Correlation of mitochondria in numerous
mouse tissues uncovered noteworthy congruity between protein levels and gene expression
levels as measured by mRNA. This recommends that the tight control of mitochondrial
biogenesis is to a great extent attained through transcriptional regulation (25). A gene is a
specific region in the DNA, containing a message to produce various chemical substances. The
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mitochondrial genome is a circular segment of DNA that comprises of 37 known genes (21, 25).
Of those 37 genes encoded by mtDNA, 13 encode for enzymes involved in OXPHOS, 22 encode
tRNA, and two encode mitochondrial rRNA (21).
Peroxisome proliferator activated receptor gamma co-activator alpha (PGC-1α) is often
referred to as the “master regulator” of mitochondrial biogenesis (21), and is known to be the
driving factor in forming oxidative type I fibers, and interrelate with many transcription factors
(76). Increased expression of PGC-1α in myotubes strongly induces mitochondrial biogenesis by
activating downstream biomarkers such as, nuclear respiratory factor 1 (NRF-1) and (NRF-2),
which initiate expression of TFAM (76). The key role of PGC-1α in mitochondrial biogenesis
has been obviously exhibited in transgenic studies (10, 41, 43). The overexpression of PGC-1α in
skeletal muscle brings about increased mitochondrial abundance, gene expression, and enhanced
physical performance (43). Interestingly, PGC-1α null mice showcase diminishes in
mitochondrial gene expression and debilitated mitochondrial function (4, 41). Further evidence
has shown PGC-1α to stimulate fatty acid oxidation, as well as improve insulin sensitivity in rats
in a stressful environment (5).
Impaired mitochondria and decreased mitochondrial density, and mtDNA content in
high-fat diet-induced obesity are closely linked to the down regulation of PGC-1α and its
downstream targets (60). Another study conducted on male rats reported that high-fat diet
feeding induced skeletal muscle oxidative capacity by increasing PGC-1α, and the number of
mitochondria in the cell (69). Moreover in the soleus muscle of high-fat diet-induced obese mice,
COX IV levels, PGC-1α, NRF-1, and TFAM gene expression were decreased, as well as, oxygen
consumption and ATP production (70). Taken together, these data indicate that PGC-1α directly
relates external stimuli to the regulation of mitochondrial biogenesis and function.
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While PGC-1α manages the expression of various mitochondrial genes, its own
expression is directed by the energy needs of the cell (22). For instance, PGC-1α is
communicated in a tissue-specific way, showing higher expression levels in tissues with higher
energy requirements (22). Also, PGC-1α expression and activity is delicate to outer indicators of
increased energy needs (22). For example, Greene et al. (21) observed an increased in PGC-1α
expression following physical activity. Moreover, the action of PGC-1α is weakened by
posttranslational adjustments of AMP-activated protein kinase (AMPK) and sirtuin1 (SIRT1),
which are themselves, enacted by an expansion in cell energy needs (37, 56). This by and large
infers that PGC-1α is a key impact in the long haul adjustment to the changing energy needs of
the cell (25).
Mitochondrial Biogenesis Assessment
Mitochondria are exceptionally polymorphic, displaying structural variants that are
dependent upon cell type, metabolic needs of the cell, and the cell cycle stage (25).
Correspondingly, mitochondrial mass shifts around different organisms and tissue types, and is
particularly needy upon the vitality necessities of the cell (25). One of the essential means by
which mitochondrial capacity may be upgraded is through the biogenesis of new mitochondrial
components (21). Miller et al. (48) suggested that the utilization of mitochondrial protein
synthesis rates (mtFSR) may be the closest genuine measure of mitochondrial biogenesis, as
these measures portray novel addition of protein components to the mitochondria in “real time".
Given that control of mitochondrial biogenesis is accomplished through transcriptional
regulation (25, 50), gene expression levels of key mitochondrial regulatory and component genes
should be utilized to affirm changes in mitochondrial number instead of size (68). For instance,
an upregulation in the expression of PGC-1α and/or NRF-1 are symbolic of expanded
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mitochondrial biogenesis (68). The branched-chain amino (BCAA), leucine, essentially
upregulates mitochondrial biogenesis as measured by gene expression levels in skeletal muscle
cells (68).
V.

Leucine

The inherent rise in obesity has sparked an interest in treatments and prevention methods that
will reverse or attenuate mitochondrial dysfunction. Aligned with these strategies, BCCAs have
shown to promote health and enhance physical performance (6). Leucine, isoleucine, and valine
are defined as BCAAs, a gathering of essential amino acids that assume critical parts in protein
synthesis and energy production (67).
Of the BCAAs, leucine is the most broadly explored because of its differing physiological
roles in mitochondrial function, protein synthesis, exercise recovery, glucose homeostasis, and
insulin activity. In humans, BCAAs comprise between fifteen and twenty-five percent of total
protein intake, and embody forty percent of the essential amino acids in body protein (2, 6). As
essential amino acid, the BCAAs must be acquired through eating, and dairy items are one of the
wealthiest wellsprings of BCAAs and of leucine specifically.
Leucine and Protein Synthesis
Both in vivo and in vitro studies have demonstrated leucine to have a unique signaling role in
the cellular energy metabolism of normal skeletal muscle cells. Leucine is an activator of
mammalian target of rapamycin (mTOR), a protein responsible for inducing muscle protein
synthesis (5). Muscle protein synthesis is stimulated by leucine through mTOR-dependent andindependent mechanisms (12). Leucine is detected through mTOR, and plays a role in the
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initiation of translation during protein synthesis. Leucine acts through mTOR independently by
activating eIF4G (eukaryotic initiation factor-4G) thereby mediating protein synthesis in the
muscle (13, 17). Under a dependent-mTOR mechanism, leucine associates eukaryotic initiation
factor-4E (eIF4E) with S6 ribosomal protein to stimulate protein synthesis (17). Dietary
supplementation with leucine has been shown to stimulate protein synthesis via insulindependent mechanisms.
Leucine has also been recognized as a key substrate in fatty acid oxidation and
mitochondrial biogenesis in murine myotubes (67, 70). A previous study proposed leucine to
regulate adipocyte lipid metabolism, and possibly serve to induce an increased flux of lipids to
skeletal muscle, thereby providing the energy fuel to support leucine-stimulated protein synthesis
(68). This “energy partitioning” effect was also seen in Zemel et al. (77), with leucine supporting
fatty acid oxidation in adipocytes concomitant with activating mTOR and thus, increasing
muscle protein synthesis. Furthermore, a 30% increase in mitochondrial mass in adipocytes, and
50% in skeletal muscle cells was observed following leucine stimulation (77).
Leucine and Mitochondrial Biogenesis
Preceding information displays a mechanism, by which leucine is assisted, by its
metabolite, β-hydroxy-β-methylbutyrate (HMB) to stimulate mitochondrial biogenesis
independent of mTOR (2). The process begins with the metabolism of leucine into αketoisocaproic acid (KIC) via an aminotransfer chemical reaction. Recent data demonstrate that
leucine is dependent upon SIRT1, an activator of PGC-1α, to initiate mitochondrial biogenesis
within these cells. Furthermore, leucine was shown to increase the gene expression of SIRT1,
and mitochondrial component genes, including PGC-1α and NRF-1 (8). These genes provide
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further verification that leucine signaling lead to an increase in mitochondrial number, rather
than mass.
The benefits of BCAA supplementation, leucine specifically, is known to promote
mitochondrial wellbeing and possibly diminish oxidative stress (6). Supplementary data
revealed, long-term administration of BCAA rich eating regimen brought about a noteworthy
expand in the lifespan of male mice, supplemented by a simultaneous increase in mitochondrial
biogenesis and lessened oxidative damage in skeletal and heart muscle (6).
Given the evidence on the seemingly diverse effects of leucine, the interest in dietary
leucine supplementation still remains prominent in research studies today. Such excitement is
due to leucine appearing as a potent activator for protein synthesis, mitochondrial biogenesis,
and lipid oxidation, which is a significant feature in understanding how skeletal muscle grows,
and regulation of metabolic health. However, the extent of leucine supplementation on anabolic
factors of the mitochondrial genome in skeletal muscle during HF feeding, to our knowledge has
yet to be fully elucidated. Considering the involvement of leucine in modulating mitochondria
abundance and function, determining the role of leucine in an obesenogenic environment can
serve as a benefit for improving metabolic health, physical performance, and disease status.
CHAPTER 3
SPECIFIC AIMS
Diet-induced obesity is caused by excessive intake of dietary fat over a period of time,
and is associated with the development of type 2 diabetes and metabolic dysfunction (9).
Mitochondria, the powerhouse of the cell, carries out cellular respiration by combining oxygen
and fuel substrates such as, fats, carbohydrates, and proteins to be broken down into cellular
energy in the form of adenosine triphosphate (ATP). The addition of new mitochondrial units,
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and proteins is important to the ability to enhance total cell mitochondrial function. In obesity,
there are a decreased number of mitochondria and oxidative capacity in skeletal muscle, thereby
leading to dysfunction muscle metabolism.
The transcriptional co-activator peroxisome proliferator-activated receptor γ co-activator
1 alpha (PGC-1 α) is commonly expressed in high oxidative tissues such as, the soleus muscle,
and is known as the ‘master regulator’ of mitochondrial biogenesis (21). PGC-1α is responsible
for binding to transcriptional factors that stimulate the activation of gene transcription and
translation involved in mitochondrial biogenesis (21). Overexpressed levels of PGC-1α may
negatively affect the activation of the downstream transcription genes, thus causing impaired
mitochondrial protein synthesis in skeletal muscle.
Anabolic factors that regulate mitochondrial biogenesis and fatty acid oxidation in
muscle include, COX IV, TFAM, mtIF2, and TUFM. A study on lean and obese, insulinresistant Zucker rats showed an increase expression of mtIF2 following exercise, however obese
animals were resistant to changes in TUFM, suggesting impaired elongation (21). Along these
lines there is now preparatory confirmation showing atypical regulation of exercise-induced gene
expression of mtIF2 and TUFM in diet-induced insulin resistance in mice.
Leucine is an essential amino acid that has been shown to attenuate diet-induced obesity
(37, 60), promote fatty acid oxidation (12), and improve mitochondrial biogenesis in skeletal
muscle (61). Supplementation with leucine has been recognized as a key mediator during chronic
inflammation by regulating glucose homeostasis and improving muscle protein synthesis (17).
Prominent research has been done on leucine supplementation in HFD feeding; however, it is
unknown how leucine affects biomarkers of the mitochondrial genome in response to a HFD.
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Therefore, the central hypothesis of this proposal is: leucine supplementation induces an
increased expression of mitochondrial biomarkers, thereby improving mitochondrial biogenesis
and mitochondrial protein synthesis in skeletal muscle of HFD-fed rats.
The purpose of this study was to determine the effect of leucine in HFD’s by targeting the
biomarkers responsible for mitochondrial biogenesis and protein synthesis in the soleus muscle.
Aim 1. Determine the effect of leucine supplementation on markers of mitochondrial
biogenesis in rats fed a high-fat diet. We hypothesize that a high fat diet supplemented with
leucine will induce mitochondrial content and density via elevated PGC1-α and COX IV levels.
Male, Sprague-Dawley rats were fed either a HFD (60% fat) or a control diet for 42 days in order
to generate diet-induced obesity. Animals were randomized into treatment groups (n =
30/group): 1) control/no leucine; 2) control/leucine; 3) high fat/ no leucine; 4) high fat/leucine.
Body weight and food intake were measured daily. At the conclusion of 42 days, animals were
sacrificed and the soleus tissue was isolated to measure the gene expression of biomarkers of
mitochondrial biogenesis. RNA isolation and real time PCR were utilized to measure gene
expression of PGC1-α and COX IV in the soleus tissue.
Aim 2. Determine the effect of leucine supplementation on biomarkers involved in
mitochondrial protein synthesis in rats fed a high fat diet. We hypothesize that a high fat diet
supplemented with leucine will induce transcription and translation activity via elevated TFAM,
mtIF2, and TUFM levels. Experiments will examine the transcription factors that are coactivated by PGC1-α including TFAM, mtIF2, and TUFM. This will allow investigators to
determine the effect of HFD’s on muscle protein synthesis and where this effect occurs. We will
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use RNA isolation and real time PCR to measure gene expression of TFAM, mtIF2, and TUFM
in the soleus tissue.
CHAPTER 4
METHODS
Animals and diets
Eight-week-old male Sprague-Dawley rats (Harlan-Teklad), weighing 220 ± 2.0g at the
beginning of the experiment, were singly housed in a secure, temperature and humiditycontrolled environment. Animals were kept on a 12:12 h reversed light-dark cycle (light 1900 –
0700), and were fed commercial pelleted diet and water ad libitum for 9 days. Once the
experiment began, rats were randomly assigned into treatment groups (n = 4-5/group): 1) control
+ glycine; 2) control + leucine; 3) high fat + glycine; 4) high fat + leucine. Rats were fed
macronutrient contents of 60% carbohydrate (CHO), 23.7% protein (PRO), 15.9% fat (control;
Table 2) or 16.9% CHO, 23.4% PRO, 60% fat (HF; Table 2) containing 32 g of either glycine or
leucine per kg of feed. A customized daily feeding schedule as previously reported Baum et al.
(6), was used to mimic human eating behavior. Throughout the experimental period, rats had ad
libitum access to water.
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Table 1
Diet composition

Table 2
Total kCal and percent energy
Macronutrient Component
Carbohydrate (CHO)
Protein (PRO)
Fat

Control Group
Kcal/Kg
% Energy
60
2390
23.7
940
15.9
630

High-Fat Group
Kcal/Kg
% Energy
872
16.9
1204
23.4
3060
60

Body weights and food intake
Body mass (BM) and food intake were monitored daily. Before feeding breakfast, rats
were placed in a container on a scale and measurements were recorded in grams (g). Rats were
given a set portion of either a chow diet (4g) or high-fat (3.1g).
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Tissue collection
After 42 days of feeding, rats were sacrificed and tissue was collected. Soleus muscles
were removed and immediately frozen in liquid nitrogen. Samples were stored at -80°C for later
analysis.
RNA isolation, cDNA synthesis, and quantitative real time PCR
Trizol reagent (Life technologies, Grand Island, NY, USA) was used to extract total RNA
as suggested by the manufacturer. The extracted RNA was DNase treated, and the concentration
and purity was determined spectrophotometrically using a (A260/A280) ratio of ≥1.6. cDNA was
reverse transcribed from 1µg of total RNA using the Superscript Vilo cDNA synthesis kit (Life
Technologies, Carlsbad, CA, USA) according to manufacturer instructions. Real Time
Polymerase Chain Reaction (PCR) was carried out per manufacturer’s instruction using the
StepOne Real-Time PCR System (Life Technologies, Applied Biosystems, Grand Island, NY),
and results were analyzed using StepOne Software. Amplification of cDNA was performed in
12.5 µL TaqMan Universal PCR Master Mix (Applied Biosystems), 1µL cDNA, 9µl RNase-free
water, 1.25µL 18S primer (VIC), and 1.25 µL primer (FAM) (for appropriate target gene) in a
final volume of 25 µL /well. Samples were incubated at 95°C for 4 min, followed by 40 cycles of
denaturation, annealing and extension at 95°C, 55°C, and 72°C respectively. TaqMan
fluorescence was measured at the end of the extension step each cycle. Fluorescence labeled
probes for PGC-1α, TFAM, TUFM, mtIF2 (FAM dyes), and 18s (VIC dye) were purchased from
Applied Biosystems and were quantified with TaqMan Universal mastermix. Fluorescence
labeled probes for COX-IV was quantified with Cyber Green Universal mastermix. The ΔCt
value [Ct (FAM) - Ct (VIC)] was calculated for each sample, using the 18s Ct as the endogenous
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control. Final quantification of gene expression was calculated using the ΔΔCt method: Ct = [ΔCt
(calibrator) – ΔCt (sample)]. Relative quantification was calculated as 2 –ΔΔCt.
Statistical analysis
The independent factors in this study were diet (C vs. HF), and treatment (leucine vs. no
leucine). Dependent variables of interest included mRNA content of PGC-1α, TFAM, mtIF2,
TUFM, and mitochondrial target protein COX-IV. A diet by treatment (2x2) ANOVA was used
to analyze data regarding each dependent variable of interest. Statistical significance was set with
an alpha value of p < 0.05. When significant F ratios were found, a two-tailed Student’s t test
post hoc analysis was used to distinguish among means. All data were analyzed using
commercial software (SAS, version 9.3, Cary, NC) and all results are reported as mean ± SEM.
CHAPTER 5
RESULTS
Muscle Mass and Body Mass Data
Immediately following extraction the soleus was weighed and recorded. There was a
decrease in the wet weight in both the normal and high-fat (HF) groups that were supplemented
with leucine compared to their respective controls (Table 3). No significant difference was seen
in the ratio of muscle mass to body weight with leucine supplementation in either group.
Beginning approximately day 20, HF rats weighed significantly more than the normal rats
(p<0.05) (Figure 1). The rats on a HFD gained significantly more weight (p < .0001) than those
fed a normal diet with values of (409.07 ± 3.01 vs. 434.52 ± 3.01), respectively (Figure 1).
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Figure 1. Body weights of rats fed normal diet (N) or HFD, supplemented with/without leucine
for 42 days. Body weights were monitored daily. Values are means ± SEM, n=30. *p < 0.05.
Table 3
Muscle Mass, Body Mass, and Muscle to Body Mass Ratio
Normal

High Fat

No Leucine

Leucine

No Leucine

Leucine

Soleus
(mg)

166.3 ± 2.4

161.2 ± 3.1

180.2 ± 2.9

173.8 ± 2.8

Body Mass
(g)

408.1 ± 3.5

410.1 ± 3.9

433.9 ± 4.7

435.2 ± 4.8

0.42 ± 0.004

0.40 ± 0.006

Muscle Mass/Body
Mass
0.41 ± 0.01
0.39 ± 0.006
(mg/g)
Note. Data are means ± SEM. The HFD contained 60% fat.

Gene Expression of Mitochondrial Transcription and Translation Factors
A significant increase (p<0.05) in mtIF2 expression was observed in the CL group, with a
4.0 fold increase compared to the control within the same group. Conversely, a blunted response
in mtIF2 expression was observed in the HFL rats (Figure 2). Although a mean decrease was
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seen in HFL, an interaction was demonstrated in the diets, with a significant increase (p = 0.018)
in mtIF2 expression in the HF group compared to the normal group.

Figure 2. Fold change comparison of mtIF2 expression in both normal and HF groups with or
without leucine supplementation.
*Shows significance within group, + Shows significance between groups
Similarly, a 5.5 fold increase in TFAM expression was seen in rats on normal and leucine
compared to their respective control (Figure 3). Although, without leucine supplementation,
TFAM expression was approximately 3.5 fold greater in the HFD rats compared to the N rats.

Figure 3. Fold change comparison of TFAM expression in both normal and HF groups with or
without leucine supplementation.
A main effect (p= 0.01) in the diet was seen in TUFM gene expression between the
normal and HF groups. Within the normal group, regardless of the treatment, TUFM gene
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expression was up regulated. However, a 1.0 fold decline in TUFM expression was demonstrated
in the HF group.
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Figure 4. Fold change comparison of TUFM expression in both normal and HF groups with or
without leucine supplementation
+ Shows significance between groups
Effects of Leucine Supplementation on Mitochondrial Biogenesis Markers in Skeletal Muscle
Markers involved in mitochondrial biogenesis including, PGC-1α and COX IV, were measured
as to allow for quantification of the response to a HF diet. It was observed that in the CL group,
PGC-1α gene expression was up regulated, however a trend decline (p=0.0724) was
demonstrated in the HFL group (Figure 5). The HF group had a slight increase (0.5 fold increase)
in PGC-1α expression compared to the normal group.
COX-IV, a marker for mitochondrial volume, was unaffected by leucine supplementation in
the HFD group (Figure 6). Although, no significance was found, COX-IV mRNA levels
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increased 4.0-fold in the normal group supplemented with leucine compared to their respective
controls.

Figure 5. Fold change comparison of PGC-1α expression in both normal and HF groups with or
without leucine supplementation.

Figure 6. Fold change comparison of COX IV expression in both normal and HF groups with or
without leucine supplementation.
*Shows significance within group
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CHAPTER 6
DISCUSSION
It is presently perceived that nutrients can interrelate with transcription factors and
contribute with biological processes. People respectably fluctuate in their individual reactions to
diet regimens, and such approaches can help to look at the impact of nutrition on skeletal muscle
function. The mitochondrion has long been involved in the pathogenesis of obesity and
metabolic dysfunction (33, 36). Beforehand, it has been demonstrated that a mitochondrial
insufficiency exists in obese people (30) and rodents (57). Nonetheless, the results of late studies
recommend that there is a separation between mitochondrial dysfunction and the progression of
obesity (3). Such a disconnection has led this study to focus on specific anabolic factors
associated with the mitochondrial genome, which may contribute to the lack of mitochondrial
efficiency.
Under normal conditions, leucine seems to stimulate skeletal muscle mitochondrial
biogenesis, as the increase of PGC-1α mRNA suggest. Leucine has been demonstrated to
stimulate SIRT-1 activity, an activator of PGC-1α to start mitochondrial biogenesis and
ultimately increase energy consumption within these cells. Previous data exhibit leucine's
stimulation of mitochondrial biogenesis is independent of mTOR through leucine's metabolite, βhydroxy-β-methylbutyrate (HMB) (8). The breakdown of leucine is required to elicit the leucineinduced stimulation on mitochondrial biogenesis. Thus, leucine is metabolized via a
transamination reaction to α-ketoisocaproic acid (KIC). The two metabolites of KIC, isovalerylCoA and HMB, along with leucine have been shown to significantly stimulate SIRT1 activity,
while the branched-chain amino acid control valine did not (8). According to these analyses, an
increment in mitochondrial number instead of mass is suggested to occur from leucine signaling.
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A different sirtuin located in the mitochondria, SIRT3, was shown to modulate SIRT1dependent pathways. SIRT3 activation leads to stimulation of mitochondrial biogenesis and
metabolism, resulting in enhanced fatty acid oxidation and a decrease in ROS production. Recent
evidence on SIRT3 null mice have shown constitutive shortages in ATP production (1), and a
propensity to develop the metabolic syndrome when exposed to a HFD (24). Such analyses
reveal the importance of SIRT3, and indicate a possibility of leucine to modulate SIRT3 as well.
It is notable, that PGC-1α gene expression appears to be already elevated in HF rats
compared to the rats in the normal condition. Increased mRNA levels of PGC-1α, a master
regulator of mitochondrial biogenesis (29), would involve the enhancement of skeletal muscle
oxidative capacity. Review that fibers with a high oxidative capacity create ATP through
oxidative phosphorylation in the mitochondrial inner membrane. It takes after that muscle cells,
which hold more mitochondria, will have a higher oxidative capacity, and enhanced fatty acid
oxidation. However, a disassociation between PGC-1α, enhancement in oxidative capacity (29),
and fatty acid oxidation (27) has been accounted for in obese rodents.
Recent evidence indicates that severely damaged or energetically dead mitochondria are
cleared from the cell via autophagic degradation through a pathway known as mitophagy (23).
The serine/threonine-protein kinase PINK1, accumulates specifically on the outer membrane of
mitochondria (18), which then recruits Parkin and the downstream autophagy machinery that
directs the defective organelles to lysosomes for degradation (39). The stresses that ultimately
result in mitophagy could explain a potential mechanism of which there is an aggregation of
“unhealthy” mitochondria associated with HF intake. Such an accumulation would essentially
prompt a rise in the content of mitochondrial components, and subsequently be erroneously
recognized as indication of mitochondrial biogenesis (29).
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Considering the fact that the HFD rats were able to upregulate primary factors regulating
mitochondrial biogenesis (PGC-1α) without a non-significant, leucine-induced enhancement of
mitochondrial biogenesis (COX-IV), this study aimed to identify potential anabolic factors
associated with the mitochondrial genome that may be unresponsive, or seen as rate-limiting in
response to leucine supplementation. These data revealed that TFAM and mtIF2, regulators of
mitochondrial transcription and translation initiation, respectively, were upregulated in rats fed a
normal chow diet when supplemented with leucine. This discovery is novel in reporting that
leucine instigates an increase in the expression of TFAM and mtIF2. Indicating enhanced
capacity for transcription and translation of mitochondrial encoded genes in normal, healthy
conditions. This data also suggests that leucine supplementation could lead to increased
metabolic proteins derived from the mtDNA in mammals. Enhanced mitochondrial protein
synthesis would likely prompt increased oxidative phosphorylation enzymes, for example, those
utilized as a part of ETC, hence providing significant benefits in metabolic health.
Indeed, collecting evidence demonstrates that HFDs are associated with an upregulation
of most anabolic processes (23), and increased expression of key mitochondrial enzymes (14,
20). This study revealed similar results showing that rats fed a HFD induced TFAM and mtIF2
mRNA expression. However, TUFM mRNA, the primary factor in mitochondrial translation
elongation was not enhanced in the HF group compared to the control group. It has additionally
been noted that mitochondrial translation factors are linked to insulin signaling through the
NFкB1/IкBKB pathway (38). More specifically, TUFM cohorts with insulin signaling through
the acknowledged translation pathway via ribosomal protein s6 (RPS6), eukaryotic translation
initiation factor 4E (eIF4E), and eukaryotic translation elongation factor 2 (eEF2) (38).
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It subsequently seems likely that such a disturbance in factors that regulate the canonical
translation pathway due to exposure to a HFD, can have unfavorable consequences for TUFM. In
addition, eIF4E-binding protein is a downstream effector of mTOR that repress translation by
binding to mRNA, and has demonstrated sensitivity to diet-induced obesity (40). These data
suggest the comparable mechanisms that oversee the expression of the canonical nuclear genome
translation pathway, for example, mTOR may be included in the regulation of TUFM, however
such an understanding obliges further examination to explain. Taken together these studies
provide novel insight into a possible mechanism for mitochondrial dysfunction in skeletal muscle
related to the translational response in a HF environment.
It is notable to mention, HFD’s attenuate the effect of leucine on mitochondrial protein
synthesis, which could represent a disruption in the signaling process. The lack of leucineinduced TUFM expression is proposed to be due to an impaired response of translation
elongation in a HFD, in this way restricting the improvement of mitochondrial proteins. Taking
into account recent studies, TUFM is the essential protein, which assumes a basic part in
translation elongation, and along these lines the completion of mitochondrial translation (21).
Despite the fact that this study did not specifically assess obese animals or protein content,
Greene et al. (21) specified a “bottleneck” point when the obese animal has reached a maximum
capacity of inducing mitochondrial translation elongation, and consequently neglect to prompt a
measure of mitochondrial protein synthesis. Such a hypothesis is because of an increment in
TUFM gene expression, however a diminished reduction in TUFM protein content following
resistant exercise in obese, Zucker rats.
Notably, a newly identified mitochondrial protein known as, AU- binding homolog of
enoyl-coenzyme A (CoA) hydrates (AUH) demonstrates a bi-functional role in RNA-binding
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activity and leucine catabolism (17). Furthermore, AUH is associated with fatty acid
degradation, and has been demonstrated to have intrinsic hydratase enzymatic activity.
Reduction or overexpression of the AUH protein is linked to defects in mitochondrial translation
that prompt changes in mitochondrial morphology, diminish mitochondrial stability, biogenesis,
and respiratory function. Regulation of leucine catabolism is paramount to monitor sufficient
leucine levels for cytoplasmic protein synthesis and to provide anaplerotic substrates to the citric
cycle located in the mitochondrial matrix (17). It therefore appears likely that mutations in the
AUH protein inhibits leucine catabolism, and mitochondrial fatty acid oxidation resulting in a
decline in mitochondrial protein synthesis during HFD conditions.
In summary, excess energy intake can be directly associated with alterations in muscle
mitochondrial activity. The rats fed a HFD showed signs of attempted mitochondrial biogenesis
indicative of the enhanced expression of PGC-1α. However, Greene et al. (21) observed no
enhancement in mitochondrial protein content, despite an induction in PGC-1α gene expression.
Thus leading to the assumption that factors downstream of PGC-1α lead to impaired
mitochondrial biogenesis in HF-induced rats. It appears that animals exposed to a HFD are able
to integrate signals to initiate an adaptive oxidative response (TFAM, mtIF2), but the failed
mitochondrial biogenesis may be due to an inadequate mitochondrial translation elongation
(TUFM) response. Such an increase in mRNA expression may represent the mitochondrial
components trying to compensate for the deleterious effects of HF intake.
This study demonstrates that the BCAA leucine, has the potential to stimulate
mitochondrial protein synthesis in skeletal muscles, at least under normal conditions. However,
leucine loses its effect on mitochondrial transcription and translation processes during exposure
to a HFD. This suggests that during HF feeding, dietary leucine elicits an incomplete response of
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mitochondrial protein synthesis as the progression of HFD-induced obesity increases. This is
important as it guides future research into the mechanisms behind this dysfunction. On
completion of this study it is need to be noted that protein content may be affected by high fat
intake and so further studies on protein analysis is warranted. Also, the assessment of a small
group number (n = 4/5) may have affected the outcome of significance, therefore a larger group
analysis may be needed to detest greater significance on the anabolic factors.
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